Abstract
Pyridoxine (PN), one of the vitamers of vitamin B6, plays an important role in the maintenance of epidermal function and is used to treat acne and rough skin. Clinical studies have revealed that PN deficiency causes skin problems such as seborrheic dermatitis and stomatitis. However, the detailed effects of PN and its mechanism of action in epidermal function are poorly understood. In this study, we examined the effects of PN on epidermal function in normal human epidermal keratinocytes and found that PN specifically causes an increase in the expression of profilaggrin mRNA, among marker genes of terminal epidermal differentiation. In addition, PN treatment caused an increase in the production of filaggrin protein in a concentration-dependent manner. Treatment with P2x purinoceptor antagonists, namely, pyridoxal phosphate-6-azo (benzene-2,4-disulfonic acid) tetrasodium salt hydrate and TNP-ATP hydrate, induced an increase in the filaggrin protein levels. Moreover, we showed that elevated filaggrin production induced upon PN treatment was suppressed by ATP (known as P2x purinoceptor agonist). This study is the first to report that PN causes an increase in filaggrin transcription and production, and these results suggest that PN-induced filaggrin production may be a useful target as a daily care component in atopic dermatitis, wherein filaggrin levels are specifically reduced.
Similar content being viewed by others
References
Rosenberg IH (2012) A history of the isolation and identification of vitamin B(6). Ann Nutr Metab 61(3):236–238
Schereiner AW et al (1952) Seborrheic dermatitis; a local metabolic defect involving pyridoxine. J Lab Clin Med 40(1):121–130
Lakshmi AV, Ramalakshmi BA (1998) Effect of pyridoxine or riboflavin supplementation on plasma homocysteine levels in women with oral lesions. Natl Med J India 11(4):171–172
Effersoe H (1954) The effect of topical application of pyridoxine ointment on the rate of sebaceous secretion in patients with seborrheic dermatitis. Acta Derm Venereol 34(3):272–278
Trezise DJ et al (1994) P2 purinoceptor antagonist properties of pyridoxal-5-phosphate. Eur J Pharmacol 259(3):295–300
Dale BA, Holbrook KA, Steinert PM (1978) Assembly of stratum corneum basic protein and keratin filaments in macrofibrils. Nature 276(5689):729–731
Resing KA, Walsh KA, Dale BA (1984) Identification of two intermediates during processing of profilaggrin to filaggrin in neonatal mouse epidermis. J Cell Biol 99(4 Pt 1):1372–1378
Lonsdale-Eccles JD et al (1984) High-molecular-weight precursor of epidermal filaggrin and hypothesis for its tandem repeating structure. Biochemistry 23(6):1239–1245
Scott IR, Harding CR (1981) Studies on the synthesis and degradation of a high molecular weight, histidine-rich phosphoprotein from mammalian epidermis. Biochim Biophys Acta 669(1):65–78
Scott IR, Harding CR (1986) Filaggrin breakdown to water binding compounds during development of the rat stratum corneum is controlled by the water activity of the environment. Dev Biol 115(1):84–92
Goldman RD, Steinert PM (1990) Cellular and molecular biology of intermediate filaments. Plenum Press, New York, pp 393–412
Seguchi T et al (1996) Decreased expression of filaggrin in atopic skin. Arch Dermatol Res 288(8):442–446
Thacher SM, Rice RH (1985) Keratinocyte-specific transglutaminase of cultured human epidermal cells: relation to cross-linked envelope formation and terminal differentiation. Cell 40(3):685–695
Dale BA et al (1985) Expression of epidermal keratins and filaggrin during human fetal skin development. J Cell Biol 101(4):1257–1269
Steven AC et al (1990) Biosynthetic pathways of filaggrin and loricrin–two major proteins expressed by terminally differentiated epidermal keratinocytes. J Struct Biol 104(1–3):150–162
Mills AA et al (1999) p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398(6729):708–713
Blanpain C et al (2006) Canonical notch signaling functions as a commitment switch in the epidermal lineage. Genes Dev 20(21):3022–3035
Okuyama R et al (2004) High commitment of embryonic keratinocytes to terminal differentiation through a Notch1-caspase 3 regulatory mechanism. Dev Cell 6(4):551–562
Yuspa SH et al (1989) Expression of murine epidermal differentiation markers is tightly regulated by restricted extracellular calcium concentrations in vitro. J Cell Biol 109(3):1207–1217
Otsuka A et al (2014) Possible new therapeutic strategy to regulate atopic dermatitis through upregulating filaggrin expression. J Allergy Clin Immunol 133(1):139–146
Palmer CN et al (2006) Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38(4):441–446
Sandilands A et al (2007) Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet 39(5):650–654
Howell MD et al (2009) Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 124(3 Suppl 2):R7–R12
Milner P et al (1990) Rapid release of endothelin and ATP from isolated aortic endothelial cells exposed to increased flow. Biochem Biophys Res Commun 170(2):649–656
Hansen M et al (1993) Intercellular calcium signaling induced by extracellular adenosine 5’-triphosphate and mechanical stimulation in airway epithelial cells. J Cell Sci 106(Pt 4):995–1004
Ferguson DR, Kennedy I, Burton TJ (1997) ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes–a possible sensory mechanism? J Physiol 505(Pt 2):503–511
Lambrecht G (2000) Agonists and antagonists acting at P2X receptors: selectivity profiles and functional implications. Naunyn Schmiedebergs Arch Pharmacol 362(4–5):340–350
North RA, Surprenant A (2000) Pharmacology of cloned P2X receptors. Annu Rev Pharmacol Toxicol 40:563–580
Pillai S, Bikle DD (1992) Adenosine triphosphate stimulates phosphoinositide metabolism, mobilizes intracellular calcium, and inhibits terminal differentiation of human epidermal keratinocytes. J Clin Invest 90(1):42–51
Dixon CJ et al (1999) Regulation of epidermal homeostasis through P2Y2 receptors. Br J Pharmacol 127(7):1680–1686
Greig AV et al (2003) Purinergic receptors are part of a signaling system for keratinocyte proliferation, differentiation, and apoptosis in human fetal epidermis. J Invest Dermatol 121(5):1145–1149
Burrell HE et al (2003) Human keratinocytes express multiple P2Y-receptors: evidence for functional P2Y1, P2Y2, and P2Y4 receptors. J Invest Dermatol 120(3):440–447
Burrell HE et al (2005) Human keratinocytes release ATP and utilize three mechanisms for nucleotide interconversion at the cell surface. J Biol Chem 280(33):29667–29676
Inoue K et al (2005) Characterization of multiple P2X receptors in cultured normal human epidermal keratinocytes. J Invest Dermatol 124(4):756–763
Khakh BS et al (2001) International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev 53(1):107–118
Author information
Authors and Affiliations
Contributions
MF collected the data and wrote the manuscript. SY and MN collected the data. ST wrote the manuscript. TS and IS involved in direction of experiment and writing the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
The authors declare that they consent for publication of this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Fujishiro, M., Yahagi, S., Takemi, S. et al. Pyridoxine stimulates filaggrin production in human epidermal keratinocytes. Mol Biol Rep 48, 5513–5518 (2021). https://doi.org/10.1007/s11033-021-06563-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-021-06563-y